Summary:
- The article discusses the results of the FAVOR III Europe trial, which compared the use of quantitative flow ratio (QFR) versus fractional flow reserve (FFR) in guiding revascularization decisions for patients with stable coronary artery disease.
- The study found that QFR was non-inferior to FFR in terms of the primary endpoint of major adverse cardiac events at one year, suggesting that QFR can be used as an alternative to FFR in clinical practice.
- The use of QFR, which is a less invasive and more convenient method for assessing coronary artery stenosis, may help to increase the adoption of physiological assessment in guiding revascularization decisions.